UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

Journal of clinical oncology, 2018-05, Vol.36 (15), p.1486-1497

2018

Volltextzugriff (PDF)

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4123-4131

2013

Volltextzugriff (PDF)

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

The Journal of experimental medicine, 2016-07, Vol.213 (8), p.1513-1535

2016

Volltextzugriff (PDF)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

Multiple sclerosis, 2018-06, Vol.24 (7), p.919-931

2018

Volltextzugriff (PDF)

A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions

Respiration, 2018-02, Vol.95 (2), p.98-105

2018

Volltextzugriff (PDF)

A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma

BMC cancer, 2018-02, Vol.18 (1), p.199-199, Article 199

2018

Volltextzugriff (PDF)

Flow cytometry in clinical pathology

Annals of clinical biochemistry, 2012-01, Vol.49 (Pt 1), p.17

2012

Volltextzugriff (PDF)

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting

Haematologica (Roma), 2009-06, Vol.94 (6), p.870-874

2009

Volltextzugriff (PDF)

Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?

Annals of clinical biochemistry, 2011-09, Vol.48 (Pt 5), p.459

2011

Volltextzugriff (PDF)

Paediatric ambiguous lineage leukaemia with monocytic differentiation at diagnosis: case series and review of literature

British journal of haematology, 2022-02, Vol.196 (3), p.e34-e39

2022

Volltextzugriff (PDF)

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

Leukemia, 2017-05, Vol.31 (5), p.1059-1068

2017

Volltextzugriff (PDF)

Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified

Journal of clinical pathology, 2022-03, Vol.75 (3), p.205

2022

Volltextzugriff (PDF)

European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation

Cytometry. Part B, Clinical cytometry, 2024-06

2024

Volltextzugriff (PDF)

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia

Blood, 2007-01, Vol.109 (2), p.674-682

2007

Volltextzugriff (PDF)

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Blood advances, 2023-05, Vol.7 (10), p.2155-2165

2023

Volltextzugriff (PDF)

Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia

Blood, 2017-12, Vol.130, p.468-468

2017

Volltextzugriff (PDF)

CD34+ STEM CELL MOBILISATION IN MS TREATMENT AND RELAPSE

Journal of neurology, neurosurgery and psychiatry, 2014-10, Vol.85 (10), p.e4.61-e4

2014

Volltextzugriff (PDF)

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions

The European respiratory journal, 2013, Vol.41 (1), p.18-24

2013

Volltextzugriff (PDF)

An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts

British journal of haematology, 2015-07, Vol.170 (1), p.80-84

2015

Volltextzugriff (PDF)

Significance of Blast CD33 Expression for Effect of Gemtuzumab Ozogamicin at Different Doses in Adult Acute Myeloid Leukemia: Results from the UK NCRI AML16/17 Trials

Blood, 2015-12, Vol.126 (23), p.320-320

2015

Volltextzugriff (PDF)

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

British journal of haematology, 2006-08, Vol.134 (3), p.273-282

2006

Volltextzugriff (PDF)

An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts

British journal of haematology, 2015-07, Vol.170 (1), p.80-84

2015

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(57)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Humans
(27)
Life Sciences & Biomedicine
(26)
Middle Aged
(18)
Male
(17)
Female
(15)
Adult
(13)
Aged
(13)
General Relativity And Quantum Cosmology
(11)
Physics
(11)
Aérospatiale, Astronomie & Astrophysique
(10)
Gravitational Waves
(10)
Physical Sciences
(10)
Physical, Chemical, Mathematical & Earth Sciences
(10)
Physique, Chimie, Mathématiques & Sciences De La Terre
(10)
Space Science, Astronomy & Astrophysics
(10)
Aged, 80 And Over
(9)
Astronomy & Astrophysics
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions

A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma

Flow cytometry in clinical pathology

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting

Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?

Paediatric ambiguous lineage leukaemia with monocytic differentiation at diagnosis: case series and review of literature

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified

European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia

CD34+ STEM CELL MOBILISATION IN MS TREATMENT AND RELAPSE

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions

An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts

Significance of Blast CD33 Expression for Effect of Gemtuzumab Ozogamicin at Different Doses in Adult Acute Myeloid Leukemia: Results from the UK NCRI AML16/17 Trials

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts

Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34- Human Acute Myeloid Leukemia

Suchergebnisse filtern